Furthermore, PIM1 conferred an acquired resistance to the PI3K inhibitors, since it appeared that PIM1 overexpression and PIK3CA mutations were mutually exclusive in treatment-naïve BC. The gene discussed is PIM1; the disease is breast cancer.